Donation of $1.6 Million Gets Your Name on Cancer Drug, FT Says
This article is for subscribers only.
Researchers at Uppsala University in Sweden are offering to name an experimental cancer drug after anyone who donates 1 million pounds ($1.6 million) to help fund its development, the Financial Times said.
Academics at the Swedish college are trying to raise 2 million pounds to pay for a clinical trial in as many as 20 people for the potential treatment of neuroendocrine cancer, the newspaper said, citing comments from the university.